Results 31 to 40 of about 8,176 (156)

Rifaximin in the treatment of hepatic encephalopathy [PDF]

open access: yes, 2011
Maddalena Diana Iadevaia, Anna Del Prete, Claudia Cesaro, Laura Gaeta, Claudio Zulli, Carmelina LoguercioDepartment of Internistica Clinica e Sperimentale, F Magrassi e A Lanzara, Hepatogastroenterology Unit, Second University of Naples, Naples ...
Gaeta L   +5 more
core  

Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders

open access: yesBritish Journal of Pharmacology, EarlyView.
Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman   +3 more
wiley   +1 more source

Unveiling Gut Homeostasis Disruption in Sepsis: Towards an Integrated Mechanistic and Translational Roadmap

open access: yesCell Proliferation, EarlyView.
Elucidating the contribution of gut‐organ axes will provide new insights for developing combined therapeutic strategies against sepsis‐associated multiple organ dysfunction. ABSTRACT Sepsis, a life‐threatening clinical syndrome precipitated by a maladaptive host response to infection, is associated with substantial morbidity and high mortality rates ...
Yichen Bao   +7 more
wiley   +1 more source

Rifaximin-alpha and other crystalline forms of rifaximin: Are there any differences? [PDF]

open access: yes
Rifaximin is an antibiotic characterized by polymorphism. It has various crystalline forms with different pharmacological characteristics. Rifaximin acts locally in the digestive tract, therefore it is important for the absorption to be minimal and for ...
Baybulatova E.A., Zyryanov S.K.
core   +1 more source

Comparison of network topology before and after rifaximin. [PDF]

open access: yes, 2013
Intersection indicates the nodes and network common to both before and after rifaximin. The table shows that the majority of nodes involved were common (intersection) between the groups while the network density (average number of neighbors and network ...
Phillip B. Hylemon (253333)   +15 more
core   +1 more source

Outcomes of a Routine Screening Protocol to Prevent Metamycoplasma and Ureaplasma Infection in Lung Transplant Recipients

open access: yesTransplant Infectious Disease, EarlyView.
This study analyzed outcomes of an early Mollicute (Mycoplasma hominis and Ureaplasma spp.) screening protocol using BAL PCR with preemptive treatment and ammonia monitoring in lung transplant recipients. This appears to be a practical and reasonably effective approach for preventing early Mollicute infection and hyperammonemia syndrome.
Lalithaa Thirunavukarasu Murugan   +5 more
wiley   +1 more source

Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy [PDF]

open access: yes, 2018
Zhida Wang,1 Pei Chu,2 Wenjin Wang2 1Comprehensive Clinical Skill Training Center, The First Hospital of Lanzhou University, Lanzhou 730030, China; 2Department of Emergency, The First Hospital of Lanzhou University, Lanzhou 730030, China Background ...
Chu P, Wang W, Wang Z
core  

The Role of the Gut Microbiota in Allogeneic Hematopoietic Cell Transplantation

open access: yesAmerican Journal of Hematology, Volume 101, Issue 8, Page 1980-1996, August 2026.
ABSTRACT Allogeneic hematopoietic cell transplantation (allo‐HCT) is an effective treatment for patients with high‐risk hematologic malignancies. Over the last decade, gut microbiota composition during allo‐HCT has been associated with patients' outcomes.
Wenjing Hao   +4 more
wiley   +1 more source

Profile of rifaximin and its potential in the treatment of irritable bowel syndrome [PDF]

open access: yes, 2015
Natalya Iorio, Zubair Malik, Ron Schey Section of Gastroenterology, Department of Medicine, Temple University Hospital, Philadelphia, PA, USA Abstract: Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by ...
Schey R, Iorio N, Malik Z
core  

Off‐Label Manipulation of Paediatric Medication Remains a Challenge in Clinical Practice: An Observational Study

open access: yesActa Paediatrica, Volume 115, Issue 7, Page 1529-1537, July 2026.
ABSTRACT Aim The aim was to observe the methods used for off‐label manipulation of medication on Norwegian paediatric wards. Methods This prospective observational study used a digital form to collect information on how medicine was manipulated on five paediatric wards in four university and local hospitals, from October 2023 to May 2024.
Randi Hamre Svendsen   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy